Download now: life sciences - whitepaper: building an investable ip portfolio
​

Make your bio(pharma) IP investment ready

​
March 22, 2026

Download PDF

Table of contents
  • Toc Heading
  • Toc Heading
Gareth Probert
Partner, UK and European Patent Attorney, UPC Representative
Rob Barker
Partner, UK and European Patent Attorney, Design Attorney, UPC Representative
Tim Belcher
Partner, UK and European Patent Attorney, UPC Representative

Whether you’re scaling or planning your next strategic step, these sessions will share practical insights to help future‑proof your IP and strengthen your investment story.

Episode 1: How to build a resilient IP portfolio in the (bio)pharma sector

How you structure and protect intellectual property can be critical to securing investment in the biopharma sector. In this first episode of EIP’s LinkedIn Live series, our biopharma IP experts examine what investors look for in an investment‑ready biopharma IP portfolio, and how companies can position their patent strategy to support funding, partnerships, and long‑term value creation.

Gareth Probert, Head of Biopharma & Chemistry, and Tim Belcher, Partner in EIP’s Biopharma team, focus on three core pillars that consistently influence investor due diligence and valuation: who owns the IP, what should be protected, and when patent applications should be filed.
‍

Episode 2: Strategic IP moves to consider when preparing for an investment round

In this second episode of EIP’s LinkedIn Live series, Tim Belcher and Rob Barker explore the strategic IP decisions biopharma companies should make ahead of investment rounds. From aligning patent strategy with investor expectations to managing disclosures, due diligence, freedom‑to‑operate, and data rooms, the session outlines practical steps to reduce risk, build credibility, and position IP as a core driver of valuation and deal success.

‍

Episode 3: A forward look at the 2026 (bio)pharma landscape and what it means for your business and IP strategy

In the final episode of EIP’s LinkedIn Live series, Gareth Probert and Robert Barker explore what the year ahead holds for biopharma investment and IP strategy. The discussion highlights renewed optimism and increasing deal activity as the sector emerges from a period of reduced investment. With major pharmaceutical companies facing significant patent cliffs, attention is shifting towards external innovation, particularly later‑stage and proof‑of‑concept assets that can replenish pipelines quickly.

The Latest Thought Leadership pieces in the Content Hub

See all articles

No items found.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

​
Interested in a career at EIP?

View Open Roles

Heading
This is some text inside of a div block.
This is some text inside of a div block.
​

Latest Insights

Showing 0 of 100
Filters
Ask the Experts: Can I get a patent for my invention?
17 August 2021
In the first article in this series, we introduced patent attorneys, and suggested that ‘How do I get a patent’ may not be the first question to ask a patent attorney.
#
Patenting
​
Ask the Experts: Can a patent attorney help your business?
10 August 2021
If you have watched the BBC programme ‘Dragons Den', you'll almost certainly have heard entrepreneurs asked about intellectual property rights, such as patents, design rights, trademarks and so on.
#
Patenting
​
Should I get my Patent Application to Grant as Fast as Possible?
28 July 2021
Why do patents take so long to grant?Progressing a patent family through to grant can take a notoriously long amount of time, particularly when an applicant is looking to protect their invention in a...
#
Patenting
​
How could internal combustion engines help drive decarbonisation?
22 July 2021
Last week, the UK Government announced that sales of new petrol and diesel heavy goods vehicles (HGVs) will be banned by 2040. The UK's Road Haulage Association supports the aim, but in a press...
#
Patenting
​
Digital event: Reality check for patenting computer-implemented simulations at the EPO
21 May 2021
Join us for a digital event on the 2 June.In its decision G1/19 (Simulations), the Enlarged Board of Appeal (EBoA) of the European Patent Office (EPO) addresses the patentability of...
#
Patenting
​
Digital event: Patent enablement in the UK – the judgments in the Regeneron and Illumina cases
09 April 2021
Join us for a digital event on the 21 April where we will be covering what you need to know about the requirement of patent enablement in the UK – the Supreme Court decision in Regeneron and the High...
#
Patenting
​
Digital event: What you need to know about the new EPO Guidelines for Examination
23 March 2021
Join us for a digital event on Tuesday 30th March covering what you need to know about the new EPO Guidelines and current EPO practice.This webinar hosted by Gareth Probert and Darren Smyth will give...
#
Patenting
​
International Women’s Day 2021: Q&A with Justyna Strzeszynska, founder & CEO of Joii
08 March 2021
This year, the International Women’s Day theme is ‘choose to challenge’ with a focus on challenging change to create a gender equal world.The day marks a call to action for accelerating women’s...
#
Patenting
​
International Women’s Day 2021: Q&A with Kate Bache, co-founder & managing director of Health and Her
08 March 2021
This year, the International Women’s Day theme is ‘choose to challenge’ with a focus on challenging change to create a gender equal world.The day marks a call to action for accelerating women’s...
#
Patenting
​
National Careers Week: How I started my career in IP by Tom Swift
05 March 2021
In support of National Careers Week, trainee patent attorney, Tom Swift discusses his journey into IP and gives advice to others looking to start a career in IP.
#
Patenting
​
Managing Designs and Trademarks after Brexit
30 December 2020
Following the end of Brexit here at EIP we can advise on the protection of your designs and trademarks.We can represent your design applications at the UK IPO, EU IPO and USPTO through our offices in...
#
Patenting
​
Brexit – what happens to your EU rights after the Transition Period?
25 November 2020
As we approach the end of the transition period, which expires on 31 December 2020, it is timely to provide an update and reminder about the impact of Brexit on EU Trademarks and Registered Community...
#
Patenting
​
BioWednesday Webinar Report: Enabling Access to Medical Technologies - Compulsory Licensing, TRIPS and FRAND
12 June 2020
On 20th May 2020 EIP Life partners Andy Sharples and Monika Rai joined One Nucleus’ BioWednesday webinar.EIP have created an event report that covers the webinar in more detail.
#
Patenting
​
IP pitfalls to avoid
31 March 2020
Partner Neil Condon of our Cardiff office explains his top IP pitfalls to avoid in this online blog article for Wales Business Insider.
#
Litigation
​
Analysis of Intel’s cellular patent portfolio
20 September 2019
Intel has built a cellular portfolio of 5G patent assets at some pace. The industry should take note, says James Seymour in this article in the September 2019 issue of Intellectual Property Magazine.
#
Patenting
​